4/3/2014 1:52:06 PM
The final diagnostics guidance on Measuring fractional exhaled nitric oxide concentration in asthma, recommending the use of Bedfont NObreath® have now been published.
The Bedfont NObreath® is mentioned in new guidance recommending the use of simple, non-invasive testing to help diagnose and treat asthma. The report is produced by NICE, the National Institute for Health and Care Excellence.
Mr Jason Smith, Commercial Manager at Bedfont Scientific said “The NObreath® monitor enables doctors, asthma specialists, GP’s and respiratory specialists to comply with ATS and ERS guidelines when testing for FeNO levels in asthma patients. Asthma patients can easily be tested and correctly assessed, thus saving time and reducing costs.
The battery powered monitor has been specifically designed to be highly portable. A large graphical colour touch screen and rapid start-up allows easy use by people of all ages.”
For more information and clinical papers on the NObreath® please visit www.bedfont.com or call a member of our Sales Team on 01622 851122.
Help employers find you! Check out all the jobs and post your resume.
comments powered by